US weight-loss biotech’s $600mn fund raise signals China’s role in drug trials – Financial Times By Healthy 411 US weight-loss biotech’s $600mn fund raise signals China’s role in drug trials Financial Times Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest